| Trial ID: | L5882 |
| Source ID: | NCT00681460
|
| Associated Drug: |
Human Recombined Insulin
|
| Title: |
Metformin in Gestational Diabetes Mellitus
|
| Acronym: |
MetGDM
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes, Gestational|Insulin Resistance
|
| Interventions: |
DRUG: human recombined insulin|DRUG: metformin
|
| Outcome Measures: |
Primary: newborn weight, first hour of life | Secondary: parameters of metabolic control in mother and newborn, insulin resistance, inflammatory reaction, oxidative stress, fetal growth,, during pregnancy and up to twelve hours after delivery
|
| Sponsor/Collaborators: |
Sponsor: K. Marcinkowski University of Medical Sciences
|
| Gender: |
FEMALE
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
78
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2008-05
|
| Completion Date: |
2013-05
|
| Results First Posted: |
|
| Last Update Posted: |
2015-05-27
|
| Locations: |
Div of Obstetrics and Women's Diseases, Dept of Obstetrics and Gynecology, K Marcinkowski Univ of Med Sciences, Poznan, 60-535, Poland
|
| URL: |
https://clinicaltrials.gov/show/NCT00681460
|
